Clinical trial
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood…
NCT00005928 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00005928 |
|---|---|
| Title | Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation |
| Official title | Effects of Angiotensin Converting Enzyme Inhibitor Therapy on Vascular Inflammation and Compliance |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Coronary Disease, Vasculitis |
| Intervention type | Drug |
| Interventions | Ramipril |
| Enrollment | 25 |
| Start date | Jun 1, 2000 |
| Completion | Feb 1, 2002 |
| First posted | Jun 29, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: